248 related articles for article (PubMed ID: 23774842)
1. Evaluation of the efficacy of imidacloprid 10 % / moxidectin 2.5 % (Advocate®, Advantage® Multi, Bayer) for the prevention of Dirofilaria repens infection in dogs.
Genchi C; Genchi M; Petry G; Kruedewagen EM; Schaper R
Parasitol Res; 2013 Aug; 112 Suppl 1():81-9. PubMed ID: 23774842
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the Adulticidal Efficacy of Imidacloprid 10 %/Moxidectin 2.5 % (w/v) Spot-on (Advocate®, Advantage® Multi) against Dirofilaria repens in Experimentally Infected Dogs.
Petry G; Genchi M; Schmidt H; Schaper R; Lawrenz B; Genchi C
Parasitol Res; 2015 Aug; 114 Suppl 1():S131-44. PubMed ID: 26152414
[TBL] [Abstract][Full Text] [Related]
3. Microfilaricidal efficacy of a single administration of Advocate(®) (Bayer Animal Health) in dogs naturally infected with Dirofilaria immitis or Dirofilaria repens.
Frangipane di Regalbono A; Di Cesare A; Traversa D; Simonato G; Poser H; Danesi P; Furnari C; Russi I; Raele DA; Crisi P; Pampurini F; Pietrobelli M
Vet Parasitol; 2016 Aug; 226():30-4. PubMed ID: 27514879
[TBL] [Abstract][Full Text] [Related]
4. The efficacy of a topically applied imidacloprid 10 % / moxidectin 2.5 % formulation (Advocate®, Advantage® Multi, Bayer) against Immature and Adult Spirocerca lupi worms in experimentally infected dogs.
Austin CM; Kok DJ; Crafford D; Schaper R
Parasitol Res; 2013 Aug; 112 Suppl 1():91-108. PubMed ID: 23779222
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of a single administration of a spot-on solution containing imidacloprid 10%/moxidectin 2.5% in eliminating Dirofilaria repens microfilariae in naturally infected dogs.
Traversa D; Aste G; Di Cesare A; Paoletti B; Di Tommaso M; Di Giulio E; Pampurini F; Tunesi C; Boari A
Vet Parasitol; 2011 Jun; 179(1-3):107-12. PubMed ID: 21435791
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the therapeutic and preventive efficacy of 2.5 % moxidectin / 10 % imidacloprid (Advocate(®), Bayer animal health) in dogs naturally infected or at risk of natural infection by Dirofilaria repens.
Hellmann K; Heine J; Braun G; Paran-Dobesova R; Svobodova V
Parasitol Res; 2011 Aug; 109 Suppl 1():S77-86. PubMed ID: 21739377
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of 10% imidacloprid + 2.5% moxidectin topical solution (Advantage Multi
Bowman DD; Ohmes CM; Hostetler JA; Keil DJ; Settje TL; Charles SD
Parasit Vectors; 2017 Nov; 10(Suppl 2):478. PubMed ID: 29143660
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of 10% imidacloprid+2.5% moxidectin for the treatment of Dirofilaria immitis circulating microfilariae in experimentally infected dogs.
McCall JW; Arther R; Davis W; Settje T
Vet Parasitol; 2014 Nov; 206(1-2):86-92. PubMed ID: 25444277
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of moxidectin microsphere sustained release formulation for the prevention of subcutaneous filarial (Dirofilaria repens) infection in dogs.
Genchi M; Pengo G; Genchi C
Vet Parasitol; 2010 May; 170(1-2):167-9. PubMed ID: 20193980
[TBL] [Abstract][Full Text] [Related]
10. Protection of dogs against canine heartworm infection 28 days after four monthly treatments with Advantage Multi® for Dogs.
Bowman DD; Grazette AR; Basel C; Wang Y; Hostetler JA
Parasit Vectors; 2016 Jan; 9():12. PubMed ID: 26746229
[TBL] [Abstract][Full Text] [Related]
11. Imidacloprid plus moxidectin topical solution for the prevention of heartworm disease (Dirofiloria immitis) in dogs.
Arther RG; Bowman DD; Slone RL; Travis LE
Parasitol Res; 2005 Oct; 97 Suppl 1():S76-S80. PubMed ID: 16228279
[TBL] [Abstract][Full Text] [Related]
12. Laboratory Evaluation of the Efficacy of 10 % Imidacloprid + 2.5 % Moxidectin Topical Solution (Advantage® Multi, Advocate®) for the Treatment of Dirofilaria immitis Circulating Microfilariae in Dogs.
Bowman DD; Charles SD; Arther RG; Settje T
Parasitol Res; 2015 Aug; 114 Suppl 1():S165-74. PubMed ID: 26152417
[TBL] [Abstract][Full Text] [Related]
13. Elimination of Dirofilaria (syn. Nochtiella) repens microfilariae in dogs with monthly treatments of moxidectin 2.5%/imidacloprid 10% (Advocate, Bayer) spot-on.
Fok E; Jacsó O; Szebeni Z; Gyorffy A; Sükösd L; Lukács Z; Schaper R
Parasitol Res; 2010 Apr; 106(5):1141-9. PubMed ID: 20165873
[TBL] [Abstract][Full Text] [Related]
14. Allergic dermatitis by Dirofilaria repens in a dog: clinical picture and treatment.
Rocconi F; Di Tommaso M; Traversa D; Palmieri C; Pampurini F; Boari A
Parasitol Res; 2012 Jul; 111(1):493-6. PubMed ID: 22290449
[TBL] [Abstract][Full Text] [Related]
15. Assessment of parasitological findings in heartworm-infected beagles treated with Advantage Multi® for dogs (10% imidacloprid + 2.5% moxidectin) and doxycycline.
Savadelis MD; Ohmes CM; Hostetler JA; Settje TL; Zolynas R; Dzimianski MT; Moorhead AR
Parasit Vectors; 2017 May; 10(1):245. PubMed ID: 28526088
[TBL] [Abstract][Full Text] [Related]
16. Experimental infection with Ancylostoma ceylanicum in dogs and efficacy of a spot on combination containing imidacloprid 10% and moxidectin 2.5% (Advocate/Advantage Multi, Bayer Animal Health).
Taweethavonsawat P; Chungpivat S; Satranarakun P; Traub RJ; Schaper R
Parasitol Res; 2010 May; 106(6):1499-502. PubMed ID: 20349196
[TBL] [Abstract][Full Text] [Related]
17. Experimental Dirofilaria immitis infection in dogs: effects of doxycycline and Advantage Multi® administration on immature adult parasites.
Chandrashekar R; Beall MJ; Saucier J; O'Connor T; McCall JW; McCall SD
Vet Parasitol; 2014 Nov; 206(1-2):93-8. PubMed ID: 25218886
[TBL] [Abstract][Full Text] [Related]
18. Chemoprophylaxis of Dirofilaria immitis (Leidy 1856) infection at a high challenge environment.
Labarthe NV; Willi LM; Paiva JP; Miranda MG; Zoreck K; Almeida FM
Parasit Vectors; 2015 Oct; 8():523. PubMed ID: 26459036
[TBL] [Abstract][Full Text] [Related]
19. Potential efficacy of monthly administrations of spot-on moxidectin 2.5%/imidacloprid 10% in the simultaneous prevention of major canine filarioses.
Traversa D; Mazzi A; Di Cesare A; Famigli Bergamini P; Fracassi F; Fanini G; Aste G; Pampurini F; Boari A
Parasitol Res; 2013 Nov; 112(11):3753-6. PubMed ID: 23925446
[TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of the safety and efficacy of 10% imidacloprid + 2.5% moxidectin topical solution for the treatment of ear mite (Otodectes cynotis) infestations in dogs.
Arther RG; Davis WL; Jacobsen JA; Lewis VA; Settje TL
Vet Parasitol; 2015 May; 210(1-2):64-8. PubMed ID: 25801226
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
